TY - JOUR
T1 - Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances "Take a Village"
AU - Felín, Mariangela Soberón
AU - Wang, Kanix
AU - Moreira, Aliya
AU - Grose, Andrew
AU - Leahy, Karen
AU - Zhou, Ying
AU - Clouser, Fatima Alibana
AU - Siddiqui, Maryam
AU - Leong, Nicole
AU - Goodall, Perpetua
AU - Michalowski, Morgan
AU - Ismail, Mahmoud
AU - Christmas, Monica
AU - Schrantz, Stephen
AU - Caballero, Zuleima
AU - Norero, Ximena
AU - Estripeaut, Dora
AU - Ellis, David
AU - Raggi, Catalina
AU - Castro, Catherine
AU - Moossazadeh, Davina
AU - Ramirez, Margarita
AU - Pandey, Abhinav
AU - Ashi, Kevin
AU - Dovgin, Samantha
AU - Dixon, Ashtyn
AU - Li, Xuan
AU - Begeman, Ian
AU - Heichman, Sharon
AU - Lykins, Joseph
AU - Villalobos-Cerrud, Delba
AU - Fabrega, Lorena
AU - Montalvo, José Luis Sanchez
AU - Mendivil, Connie
AU - Quijada, Mario R
AU - Fernández-Pirla, Silvia
AU - de La Guardia, Valli
AU - Wong, Digna
AU - de Guevara, Mayrene Ladrón
AU - Flores, Carlos
AU - Borace, Jovanna
AU - García, Anabel
AU - Caballero, Natividad
AU - Rengifo-Herrera, Claudia
AU - de Saez, Maria Theresa Moreno
AU - Politis, Michael
AU - Ross, Stephanie
AU - Dogra, Mimansa
AU - Dhamsania, Vishan
AU - Gomez, Carlos
AU - De la Torre Cifuentes, Ligia Alejandra
N1 - © The Author(s) 2022.
PY - 2022/8/16
Y1 - 2022/8/16
N2 - Purpose of Review: Review international efforts to build a global public health initiative focused on toxoplasmosis with spillover benefits to save lives, sight, cognition and motor function benefiting maternal and child health.Recent Findings: Multiple countries' efforts to eliminate toxoplasmosis demonstrate progress and context for this review and new work.Summary: Problems with potential solutions proposed include accessibility of accurate, inexpensive diagnostic testing, pre-natal screening and facilitating tools, missed and delayed neonatal diagnosis, restricted access, high costs, delays in obtaining medicines emergently, delayed insurance pre-approvals and high medicare copays taking considerable physician time and effort, harmful shortcuts being taken in methods to prepare medicines in settings where access is restricted, reluctance to perform ventriculoperitoneal shunts promptly when needed without recognition of potential benefit, access to resources for care, especially for marginalized populations, and limited use of recent advances in management of neurologic and retinal disease which can lead to good outcomes.Supplementary Information: The online version contains supplementary material available at 10.1007/s40124-022-00268-x.
AB - Purpose of Review: Review international efforts to build a global public health initiative focused on toxoplasmosis with spillover benefits to save lives, sight, cognition and motor function benefiting maternal and child health.Recent Findings: Multiple countries' efforts to eliminate toxoplasmosis demonstrate progress and context for this review and new work.Summary: Problems with potential solutions proposed include accessibility of accurate, inexpensive diagnostic testing, pre-natal screening and facilitating tools, missed and delayed neonatal diagnosis, restricted access, high costs, delays in obtaining medicines emergently, delayed insurance pre-approvals and high medicare copays taking considerable physician time and effort, harmful shortcuts being taken in methods to prepare medicines in settings where access is restricted, reluctance to perform ventriculoperitoneal shunts promptly when needed without recognition of potential benefit, access to resources for care, especially for marginalized populations, and limited use of recent advances in management of neurologic and retinal disease which can lead to good outcomes.Supplementary Information: The online version contains supplementary material available at 10.1007/s40124-022-00268-x.
U2 - 10.1007/s40124-022-00268-x
DO - 10.1007/s40124-022-00268-x
M3 - Review article
C2 - 35991908
SN - 2167-4841
SP - 1
EP - 30
JO - Current Pediatrics Reports
JF - Current Pediatrics Reports
IS - 2022
ER -